| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |